Significance of p53 mutations in AML

preview_player
Показать описание
David Sallman, MD, H. Lee Moffitt Cancer Center, Tampa, FL, outlines the significance of mutant p53 in acute myeloid leukemia (AML), and the clinical characteristics associated with this mutational profile, including 10-30% blast state, cytogenetic complexity, and severe pancytopenia. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
  1. VJHemOnc – Video Journal of Hematology & HemOnc
  2. Speaker: David Sallman
  3. Institution: H. Lee Moffitt Cancer Center & Research Institute
  4. Event: VJVirtual
  5. Event: SOHO 2020
  6. Format: Interview
Рекомендации по теме
Significance of p53 0:01:03

Significance of p53 mutations in AML

Dr. Landen Discusses 0:01:40

Dr. Landen Discusses p53 Mutations in Ovarian Cancer

p53: Guardian of 0:03:15

p53: Guardian of the Genome

p53 Tumour Suppressor 0:03:34

p53 Tumour Suppressor and MDM2

NEOPLASIA 4: p53 0:10:22

NEOPLASIA 4: p53 gene: The Guardian of the genome. functions, regulation and inactivation

p53 in cell 0:06:21

p53 in cell cycle regulation | p53 and cancer | p53 tumor suppressor.

The Role of 0:03:53

The Role of p53 in Cancer

The impact of 0:01:13

The impact of p53 mutation on survival in EGFR-mutated NSCLC patients

Significance of ERIC 0:02:23

Significance of ERIC study in identifying p53 mutants in CLL

Prion like aggregation 0:04:15

Prion like aggregation on mutant p53 in cancer

E09.1 Unraveling the 0:41:32

E09.1 Unraveling the functional impact of thousands of p53 mutations

PART 1 1:05:57

PART 1 Analysis of p53 mutations in primary tumors

The role of 0:03:27

The role of P53 in the early detection of sarcoma

The role of 0:03:25

The role of p53 mutation in LT in post MPN-AML

p53: The guardian 0:04:04

p53: The guardian of genome

p53 mutation contributes 0:02:01

p53 mutation contributes to the development of atherosclerotic cardiovascular disease: Study

Cancer: P53 Mutation 0:07:51

Cancer: P53 Mutation #Code: 88

Targeting tumor protein 0:17:46

Targeting tumor protein 53 (p53): Is there anything we can do therapeutically?

Removing the Most 0:01:31

Removing the Most Common P53 Mutation in Colorectal Cancer Halts Disease Progression

Novel strategies to 0:01:08

Novel strategies to target P53-mutant hematological malignancies

LIVER CANCER CAUSED 0:00:29

LIVER CANCER CAUSED BY MUTATION IN P53

Residual mutant p53 0:06:14

Residual mutant p53 activity linked to cancer survival in males

Dr. Shah Discusses 0:01:38

Dr. Shah Discusses P53-Mutated Mantle Cell Lymphoma

Dr. Rule on 0:01:15

Dr. Rule on Treatment Approaches for Patients With p53-Mutated MCL